 |
9 Diseases |  |
0 Trials |
|
0 Trials |  |
5 News |  |
- ||| PF-05236812 / J&J, Pfizer
Trial completion, Enrollment change: Open Label Extension Study Evaluating Safety and Tolerability of AAB-003 (PF-05236812) in Subject With Mild to Moderate Alzheimer's Disease (clinicaltrials.gov) - Sep 29, 2014
P1, N=52, Completed, Sponsor: Pfizer
Active, not recruiting --> Completed | N=104 --> 52
- || PF-05236812 / J&J, Pfizer
Enrollment closed: Open Label Extension Study Evaluating Safety and Tolerability of AAB-003 (PF-05236812) in Subject With Mild to Moderate Alzheimer's Disease (clinicaltrials.gov) - Jan 11, 2014
P1, N=104, Active, not recruiting, Sponsor: Pfizer
Active, not recruiting --> Completed | N=104 --> 52 Suspended --> Active, not recruiting
- ||| PF-05236812 / J&J, Pfizer
Trial completion: Study Evaluating The Safety Of AAB-003 (PF-05236812) In Subjects With Alzheimer's Disease (clinicaltrials.gov) - Nov 18, 2013
P1, N=88, Completed, Sponsor: Pfizer
Suspended --> Active, not recruiting Active, not recruiting --> Completed